The Series A financing for Annovation Biopharma Inc., established to develop a safer, next-generation anesthetic, is all about speed – developing an anesthetic agent from which surgical patients can be revived in minutes and creating a corporate structure that will allow a quick, profitable exit for Annovation’s investors.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?